Inhibition of oxidized-phospholipid-induced vascular smooth muscle cell proliferation by resveratrol is associated with reducing Cx43 phosphorylation

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 44, 2013, Pages 10534-10541

  Shi, Yue ^a   Hou, Xiaofeng ^b   Zhang, Xiwen ^b   Wang, Yao ^b   Chen, Yanhong ^b   Zou, Jiangang ^b  

^a QINGDAO UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

connexin 43; oxidized phospholipids; proliferation; resveratrol; vascular smooth muscle cell

Indexed keywords

CARDIOVASCULAR PROTECTIONS; CELL CYCLE ANALYSIS; CELL POPULATIONS; CONNEXIN 43; DNA SYNTHESISS; OXIDIZED PHOSPHOLIPIDS; PROLIFERATION; VASCULAR SMOOTH MUSCLE CELLS;

CELL CULTURE; CELL PROLIFERATION; DISEASES; OXIDATION; PHOSPHOLIPIDS; PHOSPHORYLATION;

RESVERATROL;

CONNEXIN 43; PHOSPHOLIPID; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT;

ANIMALS; AORTA; ATHEROSCLEROSIS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CONNEXIN 43; DOWN-REGULATION; HUMANS; MYOCYTES, SMOOTH MUSCLE; OXIDATION-REDUCTION; PHOSPHOLIPIDS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 84887754577     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf4036723     Document Type: Article

References (35)

1. Auge, N.; Garcia, V.; Maupas-Schwalm, F.; Levade, T.; Salvayre, R.; Negre-Salvayre, A. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways Arterioscler., Thromb., Vasc. Biol 2002, 22, 1990-5
2. Auge, N.; Maupas-Schwalm, F.; Elbaz, M.; Thiers, J. C.; Waysbort, A.; Itohara, S.; Krell, H. W.; Salvayre, R.; Negre-Salvayre, A. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation Circulation 2004, 110, 571-8
3. Bedel, A.; Negre-Salvayre, A.; Heeneman, S.; Grazide, M. H.; Thiers, J. C.; Salvayre, R.; Maupas-Schwalm, F. E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein Circ. Res. 2008, 103, 694-701
4. Doran, A. C.; Meller, N.; McNamara, C. A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis Arterioscler., Thromb., Vasc. Biol. 2008, 28, 812-9
5. Furnkranz, A.; Schober, A.; Bochkov, V. N.; Bashtrykov, P.; Kronke, G.; Kadl, A.; Binder, B. R.; Weber, C.; Leitinger, N. Oxidized phospholipids trigger atherogenic inflammation in murine arteries Arterioscler., Thromb., Vasc. Biol. 2005, 25, 633-8
6. Yeh, M.; Gharavi, N. M.; Choi, J.; Hsieh, X.; Reed, E.; Mouillesseaux, K. P.; Cole, A. L.; Reddy, S. T.; Berliner, J. A. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway J. Biol. Chem. 2004, 279, 30175-81
7. Leitinger, N. Oxidized phospholipids as modulators of inflammation in atherosclerosis Curr. Opin. Lipidol. 2003, 14, 421-30
8. Watson, A. D.; Navab, M.; Hama, S. Y.; Sevanian, A.; Prescott, S. M.; Stafforini, D. M.; McIntyre, T. M.; Du, B. N.; Fogelman, A. M.; Berliner, J. A. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein J. Clin. Invest. 1995, 95, 774-82
9. Berliner, J. A.; Heinecke, J. W. The role of oxidized lipoproteins in atherogenesis Free Radical Biol. Med. 1996, 20, 707-27
10. Furnkranz, A.; Leitinger, N. Regulation of inflammatory responses by oxidized phospholipids: Structure-function relationships Curr. Pharm. Des. 2004, 10, 915-21
11. Fruhwirth, G. O.; Moumtzi, A.; Loidl, A.; Ingolic, E.; Hermetter, A. The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells Biochim. Biophys. Acta 2006, 1761, 1060-9
12. Berliner, J. A.; Watson, A. D. A role for oxidized phospholipids in atherosclerosis N. Engl. J. Med. 2005, 353, 9-11
13. Leitinger, N.; Tyner, T. R.; Oslund, L.; Rizza, C.; Subbanagounder, G.; Lee, H.; Shih, P. T.; Mackman, N.; Tigyi, G.; Territo, M. C.; Berliner, J. A.; Vora, D. K. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 12010-5
14. Watson, A. D.; Leitinger, N.; Navab, M.; Faull, K. F.; Horkko, S.; Witztum, J. L.; Palinski, W.; Schwenke, D.; Salomon, R. G.; Sha, W.; Subbanagounder, G.; Fogelman, A. M.; Berliner, J. A. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo J. Biol. Chem. 1997, 272, 13597-607
15. Watson, A. D.; Subbanagounder, G.; Welsbie, D. S.; Faull, K. F.; Navab, M.; Jung, M. E.; Fogelman, A. M.; Berliner, J. A. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein J. Biol. Chem. 1999, 274, 24787-98
16. Jia, G.; Cheng, G.; Gangahar, D. M.; Agrawal, D. K. Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway J. Mol. Cell. Cardiol. 2008, 44, 882-90
17. Blackburn, J. P.; Peters, N. S.; Yeh, H. I.; Rothery, S.; Green, C. R.; Severs, N. J. Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis Arterioscler., Thromb., Vasc. Biol. 1995, 15, 1219-28
18. Chadjichristos, C. E.; Matter, C. M.; Roth, I.; Sutter, E.; Pelli, G.; Luscher, T. F.; Chanson, M.; Kwak, B. R. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice Circulation 2006, 113, 2835-43
19. Kwak, B. R.; Veillard, N.; Pelli, G.; Mulhaupt, F.; James, R. W.; Chanson, M.; Mach, F. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice Circulation 2003, 107, 1033-9
20. Johnstone, S. R.; Kroncke, B. M.; Straub, A. C.; Best, A. K.; Dunn, C. A.; Mitchell, L. A.; Peskova, Y.; Nakamoto, R. K.; Koval, M.; Lo, C. W.; Lampe, P. D.; Columbus, L.; Isakson, B. E. MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation Circ. Res. 2012, 111, 201-11
21. Johnstone, S. R.; Ross, J.; Rizzo, M. J.; Straub, A. C.; Lampe, P. D.; Leitinger, N.; Isakson, B. E. Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation Am. J. Pathol. 2009, 175, 916-24
22. Baur, J. A.; Sinclair, D. A. Therapeutic potential of resveratrol: The in vivo evidence Nat. Rev. Drug Discovery 2006, 5, 493-506
23. Delmas, D.; Jannin, B.; Latruffe, N. Resveratrol: Preventing properties against vascular alterations and aging Mol. Nutr. Food Res. 2005, 49, 377-95
24. Zou, J. G.; Huang, Y. Z.; Chen, Q.; Wei, E. H.; Hsieh, T. C.; Wu, J. M. Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoprotein Biochem. Mol. Biol. Int. 1999, 47, 1089-96
25. Cai, J. B.; Zhang, Z. H.; Xu, D. J.; Qian, Z. Y.; Wang, Z. R.; Huang, Y. Z.; Zou, J. G.; Cao, K. J. Negative regulation of quinone reductase 2 by resveratrol in cultured vascular smooth muscle cells Clin. Exp. Pharmacol. Physiol. 2008, 35, 1419-25
26. Alessi, D. R.; Cuenda, A.; Cohen, P.; Dudley, D. T.; Saltiel, A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo J. Biol. Chem. 1995, 270, 27489-94
27. Chu, L. M.; Lassaletta, A. D.; Robich, M. P.; Sellke, F. W. Resveratrol in the prevention and treatment of coronary artery disease Curr. Atheroscler. Rep. 2011, 13, 439-46
28. Zhang, X.; Wang, Y.; Yang, W.; Hou, X.; Zou, J.; Cao, K. Resveratrol inhibits angiotensin II-induced ERK1/2 activation by downregulating quinone reductase 2 in rat vascular smooth muscle cells J. Biomed. Res. 2012, 26, 103-9
29. Kurin, E.; Atanasov, A. G.; Donath, O.; Heiss, E. H.; Dirsch, V. M.; Nagy, M. Synergy study of the inhibitory potential of red wine polyphenols on vascular smooth muscle cell proliferation Planta Med. 2012, 78, 772-8
30. Zghonda, N.; Yoshida, S.; Araki, M.; Kusunoki, M.; Mliki, A.; Ghorbel, A.; Miyazaki, H. Greater effectiveness of epsilon-viniferin in red wine than its monomer resveratrol for inhibiting vascular smooth muscle cell proliferation and migration Biosci. Biotechnol. Biochem. 2011, 75, 1259-67
31. Poussier, B.; Cordova, A. C.; Becquemin, J. P.; Sumpio, B. E. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis J. Vasc. Surg. 2005, 42, 1190-7
32. Plenz, G.; Ko, Y. S.; Yeh, H. I.; Eschert, H.; Sindermann, J. R.; Dorszewski, A.; Hofnagel, O.; Robenek, H.; Breithardt, G.; Severs, N. J. Upregulation of connexin43 gap junctions between neointimal smooth muscle cells Eur. J. Cell Biol. 2004, 83, 521-30
33. Cai, W.; Ruan, L. M.; Wang, Y. N.; Chen, J. Z. Effects of angiotensin II on connexin 43 of VSMCs in arteriosclerosis J. Zhejiang Univ. Sci. B 2006, 7, 648-53
34. Bochkov, V. N.; Mechtcheriakova, D.; Lucerna, M.; Huber, J.; Malli, R.; Graier, W. F.; Hofer, E.; Binder, B. R.; Leitinger, N. Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT Blood 2002, 99, 199-206
35. Yang, C. M.; Chien, C. S.; Hsiao, L. D.; Pan, S. L.; Wang, C. C.; Chiu, C. T.; Lin, C. C. Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway Br. J. Pharmacol. 2001, 132, 1531-41